rs72556260
Positions:
Variant summary
Our verdict is Likely pathogenic. Variant got 8 ACMG points: 8P and 0B. PM2PP3_StrongPP5_Moderate
The NM_000531.6(OTC):c.418G>C(p.Ala140Pro) variant causes a missense change involving the alteration of a conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Likely pathogenic (★).
Frequency
Genomes: not found (cov: 23)
Consequence
OTC
NM_000531.6 missense
NM_000531.6 missense
Scores
11
4
2
Clinical Significance
Conservation
PhyloP100: 9.54
Genes affected
OTC (HGNC:8512): (ornithine transcarbamylase) This nuclear gene encodes a mitochondrial matrix enzyme. The encoded protein is involved in the urea cycle which functions to detoxify ammonia into urea for excretion. Mutations in this enzyme lead to ornithine transcarbamylase deficiency, which causes hyperammonemia. [provided by RefSeq, May 2022]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Likely_pathogenic. Variant got 8 ACMG points.
PM2
Very rare variant in population databases, with high coverage;
PP3
MetaRNN computational evidence supports a deleterious effect, 0.996
PP5
Variant X-38401306-G-C is Pathogenic according to our data. Variant chrX-38401306-G-C is described in ClinVar as [Likely_pathogenic]. Clinvar id is 97196.Status of the report is criteria_provided_single_submitter, 1 stars.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
OTC | NM_000531.6 | c.418G>C | p.Ala140Pro | missense_variant | 5/10 | ENST00000039007.5 | NP_000522.3 | |
OTC | NM_001407092.1 | c.418G>C | p.Ala140Pro | missense_variant | 7/12 | NP_001394021.1 | ||
OTC | XM_017029556.2 | c.418G>C | p.Ala140Pro | missense_variant | 5/9 | XP_016885045.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
OTC | ENST00000039007.5 | c.418G>C | p.Ala140Pro | missense_variant | 5/10 | 1 | NM_000531.6 | ENSP00000039007 | P1 | |
OTC | ENST00000488812.1 | n.455G>C | non_coding_transcript_exon_variant | 5/6 | 5 | |||||
OTC | ENST00000643344.1 | c.*168G>C | 3_prime_UTR_variant, NMD_transcript_variant | 6/11 | ENSP00000496606 |
Frequencies
GnomAD3 genomes Cov.: 23
GnomAD3 genomes
Cov.:
23
GnomAD4 exome Cov.: 28
GnomAD4 exome
Cov.:
28
GnomAD4 genome Cov.: 23
GnomAD4 genome
Cov.:
23
ClinVar
Significance: Likely pathogenic
Submissions summary: Pathogenic:2
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
Ornithine carbamoyltransferase deficiency Pathogenic:1
Likely pathogenic, criteria provided, single submitter | clinical testing | Women's Health and Genetics/Laboratory Corporation of America, LabCorp | Dec 15, 2016 | Variant summary: The OTC c.418G>C (p.Ala140Pro) variant involves the alteration of a conserved nucleotide and results in a replacement of a small size and hydrophobic Alanine (A) with a medium size and hydrophobic Proline (P) in the Carbamoyl phosphate binding domain of the OTC enzyme (ACMG-PM1). 5/5 in silico tools predict a damaging outcome for this substitution (ACMG-PP3). This variant is absent form the general population (ExAC) (ACMG-PM2) while it was reported in at-least 3 biochemically and clinically well characterized neonatal onset OTC deficiency patients indicating causality. In addition, at-least one clinical diagnostic laboratory has classified this variant as pathogenic (ACMG-PP5). However, the effect of this variant on functional OTC enzyme deficiency has not been reported. Taken together, this variant is classified as Likely Pathogenic. - |
not provided Pathogenic:1
Pathogenic, no assertion criteria provided | literature only | GenMed Metabolism Lab | - | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Pathogenic
BayesDel_addAF
Pathogenic
D
BayesDel_noAF
Pathogenic
CADD
Pathogenic
DANN
Uncertain
DEOGEN2
Pathogenic
D
FATHMM_MKL
Pathogenic
D
LIST_S2
Uncertain
D
M_CAP
Pathogenic
D
MetaRNN
Pathogenic
D
MetaSVM
Pathogenic
D
MutationAssessor
Pathogenic
H
MutationTaster
Benign
D
PrimateAI
Uncertain
T
PROVEAN
Uncertain
D
REVEL
Pathogenic
Sift
Pathogenic
D
Sift4G
Benign
T
Polyphen
D
Vest4
MutPred
Loss of stability (P = 0.0812);
MVP
MPC
ClinPred
D
GERP RS
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at